Is Emerald Health Therapeutics Inc a Buy? -- The Motley Fool
There's good news and there's bad news for Emerald Health Therapeutics Inc (NASDAQOTH:EMHTF) shareholders. The good news is that the marijuana stock jumped close to 50% higher in August. The bad news is that Emerald Health's share price is still down nearly 20% year to date.
The more important news for investors, though, is that none of this matters when it comes to what might happen next for Emerald Health. What's really important is how well the company is positioned to grow. Is Emerald Health Therapeutics a buy? Here's what you need to know.
Image source: Getty Images.
Pretty much every Canadian marijuana grower hopes to capitalize on two tremendous opportunities. The first opportunity is the country's recreational cannabis market, which is scheduled to open for business on Oct. 17, 2018. The second opportunity is the rapidly expanding global medical cannabis market.
Emerald Health appears to be on track with one major prerequisite for succeeding in the Canadian recreational market -- building production capacity. The company stated in June that it was on schedule with retrofitting the 1.1-million-square-foot facility that Village Farms(NASDAQ:VFF) contributed to the two companies' joint venture, Pure Sunfarms. This joint venture received a cannabis sales license from Health Canada on July 27, 2018. The entire facility is expected to be operational next year.
- Emerald Health Therapeutics, Inc. (EMHTF, EMH.V) Stock Profile - TNMNews.comthenationalmarijuananews.comJune 14, 2018
- Better Marijuana Stock: Aphria vs. Emerald Health Therapeutics -- The Motley Foolwww.fool.comApril 24, 2018
- Emerald Health Therapeutics Stock Lifted by Takeover Speculationsmallcappower.comNovember 15, 2017
- Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Is An Exciting Cannabis Play - Insider Financialinsiderfinancial.comSeptember 20, 2018